1-6 of 6
Authors: Jizhi Ge
Journal Article
ACCEPTED MANUSCRIPT
SWI/SNF complexes govern ontology-specific transcription factor function in MYC-subtype atypical teratoid rhabdoid tumor
Neuro-Oncology, noaf081, https://doi.org/10.1093/neuonc/noaf081
Published: 23 March 2025
Journal Article
DDEL-19. DRUG-TUMOR RESIDENCE TIME DRIVES EFFICACY OF CONVECTION-ENHANCED DELIVERY IN H3 K27-ALTERED DIFFUSE MIDLINE GLIOMA
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii125, https://doi.org/10.1093/neuonc/noae165.0485
Published: 11 November 2024
Journal Article
DDEL-05. PHARMACOKINETIC ASSESSMENT OF CONVECTION-ENHANCED DELIVERY OF SMALL MOLECULE DRUGS FOR H3 K27-ALTERED DIFFUSE MIDLINE GLIOMA
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v102, https://doi.org/10.1093/neuonc/noad179.0384
Published: 10 November 2023
Journal Article
DIPG-15. CONCURRENT GB-13 (IL13.E13K-PE4E) IMPROVES THE EFFICACY OF RADIATION THERAPY IN DIFFUSE INTRINSIC PONTINE GLIOMA
Neuro-Oncology, Volume 25, Issue Supplement_1, June 2023, Page i16, https://doi.org/10.1093/neuonc/noad073.062
Published: 12 June 2023
Journal Article
DIPG-16. ACUTE VERSUS PROLONGED CONVECTION-ENHANCED DELIVERY OF ALISERTIB INTO H3 K27M-MUTANT MODELS OF DIFFUSE MIDLINE GLIOMA
Neuro-Oncology, Volume 25, Issue Supplement_1, June 2023, Page i16, https://doi.org/10.1093/neuonc/noad073.063
Published: 12 June 2023
Journal Article
STAT3 is a biologically relevant therapeutic target in H3K27M-mutant diffuse midline glioma
Neuro-Oncology, Volume 24, Issue 10, October 2022, Pages 1700–1711, https://doi.org/10.1093/neuonc/noac093
Published: 09 April 2022
